Constitutional Court Takes On Landmark Bid-Rigging Case

The Constitutional Court of Korea is set to hear its first case under the trial review system, a landmark decision that has captured national attention. The case involves the pharmaceutical company Green Cross and a complex legal battle over bid-rigging allegations. This marks a significant moment for the nation's judiciary, as the court will examine whether the Supreme Court's divergent rulings in criminal and administrative cases related to the same matter contain unconstitutional elements.

The Green Cross case stems from accusations of bid-rigging in three vaccine procurement tenders issued by the Korea Disease Control and Prevention Agency between 2017 and 2019. The company was fined 2.035 billion won by the Fair Trade Commission. However, the legal proceedings have taken a convoluted path, with conflicting judgments from different courts. While a lower criminal court initially found Green Cross guilty, an appellate court later acquitted the company, citing a lack of substantial competition. This discrepancy in rulings is at the heart of the Constitutional Court's review.

This case is particularly noteworthy because it scrutinizes the Supreme Court's decision to dismiss the administrative lawsuit through a summary dismissal, a procedure that bypasses in-depth review. The Constitutional Court's ruling will set a precedent for how such cases are handled in the future, potentially influencing the interpretation of legal procedures and the balance of power between different branches of the judiciary. The nation watches with keen interest to see how the Constitutional Court navigates this intricate legal landscape and what implications its decision will have on the principle of due process and the integrity of the judicial system.